Amcor plc (AMCR) Released its Q4 2025 Results, Here's What You Need to Know

Amcor plc (NYSE:AMCR) is one of the Undervalued Cyclical Stocks to Buy According to Hedge Funds. On August 14, Amcor plc (NYSE:AMCR) released its fiscal Q4 2025 results.

Management highlighted its all-stock acquisition of Berry Global, which was completed on April 30. This move expanded the company’s portfolio and led the net sales to reach $5.08 billion, up 43% year-over-year. Moreover, the adjusted EBITDA rose 43% during the same time to reach $789 million.

For the full year, Amcor plc (NYSE:AMCR) delivered net sales of $15 billion, up 11% year-over-year. Looking ahead, management expects adjusted EPS between $0.8 and $0.83, reflecting a 12% to 17% increase. Moreover, the free cash flow is projected to be between $1.8 billion and $1.9 billion.

Amcor plc (NYSE:AMCR) provides packaging solutions for consumer and healthcare products. It makes sustainable, flexible, and rigid packaging for food, beverages, pharmaceuticals, and personal care items.

While we acknowledge the potential of AMCR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.